Fechar
When talking about organ transplantation, you immediately think of compatibility between receptor and donor. Compatibility is a crucial requirement for a transplant to occur, but there is another factor that is also determinant for the success of this procedure: antibodies. Every day new resources are developed that can bring benefits to patients awaiting a transplant.
Thinking about it on February 4 to 6, Biometrix promoted the I Symposium HLA MAtchmaker, in Curitiba. The event was aimed at introducing the new update of the HLA Fusion 4.3 analysis software to users, with an emphasis on the HLA Matchmaker tool. HLA MAtchmaker is a computer algorithm developed to assist in the detailed analysis of antigen/antibody reactions in transplantation. With this more detailed analysis, it is possible to predict (and establish strategies to combat) and even avoid episodes of rejection.
To participate in the symposium, 39 laboratories were confirmed from all over Brazil, encompassing most of our clients. Many of these laboratories are national references and work with a high demand for this type of exams. We brought two speakers from the American company One Lambda, which has been operating for over 20 years in the field of transplant diagnoses, both with a high level of knowledge and extensive experience in the area. They are specialists who work directly with laboratories around the world, providing training, training and support.
At the event, a full day was devoted to the training of the Biometrix scientific support team, in order to maintain our constant improvement. The other two days were intended for Biometrix customers, making not only presentations, but creating groups of discussions, suggestions and improvements.
In addition to a lot of knowledge and shared experiences, participants were able to enjoy free Quick Massage sessions and a dinner party at the end of the first day of training.
Our mission is to provide excellence in transplant solutions through the provision of quality products and services. To do this, bringing information of innovations, updates and technical-scientific knowledge in the area of histocompatibility is fundamental, since we have seen the constant innovations in this area.
